In addition, DPSC-CM alleviates hyposalivation due to SS by decreasing the inflammatory cytokine expression, inducing Tregs in the spleen via the TGF-β/Smad pathway, regulating the local inflammatory microenvironment, and decreasing apoptosis in SMGs. This evidence concerns the gene TGFB1 and synovial sarcoma.